CIC
MED icon

Chase Investment Counsel’s Medifast MED Stock Holding History

Chase Investment Counsel’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-970
Closed -$274K – 108
2021
Q2 		$274K Hold
970
– – 0.11% 92
2021
Q1 		$205K Buy
+970
New +$232K 0.09% 96

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Chase Investment Counsel's MED Position: Q3 2021 in Review

Chase Investment Counsel sold out of Medifast (MED) in Q3 2021, closing a stake of 970 shares — an estimated $274K sold.

Chase Investment Counsel first reported a position in MED in Q1 2021 and held it in 2 quarters. The position peaked at $274K in Q2 2021. 296 funds tracked by Wall St. Rank hold MED as of Q3 2021.

  • Chase Investment Counsel reported no remaining Medifast position as of Q3 2021 after selling out during the quarter.
  • Chase Investment Counsel sold 970 Medifast shares in Q3 2021, an estimated $274K.
  • Chase Investment Counsel first reported a position in Medifast in Q1 2021 and held it in 2 quarters.
  • Chase Investment Counsel's Medifast position peaked at $274K in Q2 2021.
  • 296 funds tracked by Wall St. Rank held Medifast as of Q3 2021.

Based on Chase Investment Counsel's 13F filing for Q3 2021, filed 4 Nov 2021.